Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
Key facts
- Who runs it
- Institute of Gastroenterology and Hepatology, Vietnam
- Where
- Vietnam1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 380 people, planned
- Started
- 18 Aug 2025
- Planned end
- 31 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- GERCCare mobile app
- Record updated
- 17 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- ≥18 years old
- Presents with typical GERD symptoms (regurgitation, heartburn)
- Owns a smartphone and capable of using smartphone applications
Who cannot take part
- Acute GI conditions (upper GI bleeding, acute peptic ulcer…)
- GI malignancy (esophageal cancer, gastric cancer…)
- Severe chronic comorbidities (heart failure, liver failure, chronic kidney disease…)
- Pregnancy, alcohol abuse, mental health conditions impacting medication adherence or app usage
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Gerd
This trial is currently available in Vietnam.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Adherence to GERD treatment, including medication, diet, and lifestyle, is essential for symptom control and complication prevention, yet adherence rates remain low due to various demographic and clinical factors. Digital therapeutics, particularly mobile health applications, have shown promising potential in supporting chronic disease management and improving patient outcomes.
Read full original descriptionShow less
The GERDCare mobile application was developed with direct input from gastrointestinal experts. It is designed to enhance treatment adherence and patient engagement by offering features such as educational resources, symptom tracking, medication reminders, and direct communication between patients and physicians.
The investigators are conducting a single-center, open-label, randomized controlled trial to evaluate the effectiveness of using GERDCare in improving patient adherence. Patients are followed up after four weeks of GERD treatment.
The 2 groups in the trial
- Using GERDCareTreatment being tested
Using the mobile phone application GERDCare (with detailed instructions provided during recruitment)
Treatment: GERCCare mobile app
- Not using GERDCareNo study treatment, for comparison
Not using the smartphone application GERDCare
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07125521, who can take part
- Record updated
- 17 June 2026